Discover 243 paid clinical trials in Syracuse, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Syracuse is the medical research centre of central New York, and most of its trial activity runs through one institution: SUNY Upstate Medical University, the region's only academic medical centre and the largest employer in central New York. Cancer research leads the list, with ovarian cancer, lung cancer, and lymphoma studies recruiting through both cooperative groups such as the Alliance for Clinical Trials in Oncology and the National Cancer Institute and through industry sponsors, and migraine and Crohn's disease studies appear alongside them.
Filter
2
Filter results
Results: 243
Synergy Between Choline and DHA
for
Pregnancy
Location: Ithaca NY
Sponsor: Cornell University
Sex: Female
Age: 21 - 40
Code: NCT03194659
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
for
Non Small Cell Lung Cancer
Location: Ithaca NY, Morristown NJ, White Plains NY, Stamford CT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312137
Phase3, Recruiting
Heme and Non-heme Iron Intakes, Gut Microbiota, and Influence on Host Iron Absorption
for
Anemia, Iron Deficiency, Iron Overload
Location: Ithaca NY
Sponsor: Cornell University
Sex: All
Age: 18 - 40
Code: NCT06146608
Recruiting
Advanced Cooking Education Full Scale Study
for
Adolescent Behavior, Nutrition, Healthy
Location: Ithaca NY
Sponsor: Cornell University
Sex: All
Age: 0+
Code: NCT06558396
Recruiting
Dietary Iron Requirements
for
Iron Absorption
Location: Ithaca NY, Baton Rouge LA
Sponsor: Pennington Biomedical Research Center
Sex: All
Age: 18 - 50
Code: NCT07139821
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Ithaca NY, Hackensack NJ, New York NY, The Bronx NY,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase3, Recruiting
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Syracuse NY, Stamford CT, East Setauket NY,
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma